CLDX — Celldex Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Celldex Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	408	305	424	725	519
Net Total Accounts Receivable
Net Total Receivables	0.172	0.347	2.63	0.7	2.02
Prepaid Expenses
Total Current Assets	411	318	432	747	535
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6.52	7.75	6.64	8.24	7.77
Net Intangible Assets
Other Long Term Assets
Total Assets	445	353	466	792	583
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	16.5	18.6	31.1	39.5	51
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	25.2	26.5	36.5	45.3	55.8
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	419	326	429	747	527
Total Liabilities & Shareholders' Equity	445	353	466	792	583
Total Common Shares Outstanding